© 2004 by Oxford University Press
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2004 Oxford University Press
CORRESPONDENCE |
Re: Randomized Trial of Adjuvant Therapy in Colon Carcinoma: 10-Year Results of NSABP Protocol C-01
Affiliation of authors: Department of Hematology/Oncology, University of Arkansas Medical Sciences, Little Rock
Correspondence to: Mir Asif Alikhan, MD, Department of Hematology/Oncology, University of Arkansas Medical Sciences, Little Rock, AR 72205 (e-mail: alikhanmira@uams.edu)
| The first 10% of the full text of this article appears below. |
We read with great interest the first report on long-term (10-year) outcomes of adjuvant chemotherapy in colon cancer in the Journal (1). The fluorouracil-based regimens in this report demonstrate the benefit of
Response to this Correspondence
![]()
CiteULike
Connotea
Del.icio.us What's this?
J Natl Cancer Inst 2004 96: 1794.